In 1996, the U.S. Food & Drug Administration (FDA) approved the first transvaginal mesh device. The device was created to treat women with pelvic organ prolapse or “POP,” as it’s more commonly known. POP is a medical condition which causes pelvic organs to wander or drop out of place. In theory, transvaginal mesh was...Read More